Nanoformulation of paclitaxel to enhance cancer therapy.
about
High throughput screening of natural products for anti-mitotic effects in MDA-MB-231 human breast carcinoma cellsRelease kinetics study of poorly water-soluble drugs from nanoparticles: are we doing it right?New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth.A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer.Nanoformulated water-soluble paclitaxel to enhance drug efficacy and reduce hemolysis side effect.
P2860
Nanoformulation of paclitaxel to enhance cancer therapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Nanoformulation of paclitaxel to enhance cancer therapy.
@en
Nanoformulation of paclitaxel to enhance cancer therapy.
@nl
type
label
Nanoformulation of paclitaxel to enhance cancer therapy.
@en
Nanoformulation of paclitaxel to enhance cancer therapy.
@nl
prefLabel
Nanoformulation of paclitaxel to enhance cancer therapy.
@en
Nanoformulation of paclitaxel to enhance cancer therapy.
@nl
P2093
P2860
P356
P1476
Nanoformulation of paclitaxel to enhance cancer therapy.
@en
P2093
James Z Xing
Quanrong Gu
Xiaojing Zhang
P2860
P304
P356
10.1177/0885328212446822
P577
2012-05-04T00:00:00Z